CLINICAL_TRIALS
trial_result
· 2026-03-13
Clinical Trial Update: A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures [Phase 3]
Summary
A Phase 3 randomized trial evaluating XEN1101 versus placebo for focal onset seizures has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Xenon Pharmaceuticals Inc. | Conditions: Focal Onset Seizures | Phase 3 | Status: COMPLETED